Sanofi, Michael J. Fox Foundation to Test Parkinson’s Drug

by Angela Nazworth | April 19, 2012 3:48 pm

The Michael J. Fox Foundation today announced that it will team up with French drugmaker, Sanofi (NYSE:SNY[1]) to test an experimental treatment for Parkinson’s disease.

The foundation started by the actor, who was diagnosed with young-onset Parkinson’s disease in 1991, will sponsor a clinical trial to study a drug that targets cognitive dysfunction, a severe, but lesser known symptom of the disease. Currently, not many treatments are available for cognitive impairment in Parkinson’s.

“Cognitive dysfunction is marked by a big mixed bag of pathology,” Jamie Eberling, associate director of research programs at MJFF said[2] on the foundation’s blog. “Different processes in different parts of the brain affect individuals with Parkinson’s in different ways.”

Including the collaboration with Sanofi, the MJFF has devoted more than $16 million toward cognitive dysfunction research.

Endnotes:
  1. SNY: http://studio-5.financialcontent.com/investplace/quote?Symbol=SNY
  2. said: http://blog.michaeljfox.org/2012/04/cognition-targeted-research-catches-2/

Source URL: http://investorplace.com/2012/04/sanofi-michael-j-fox-foundation-to-test-parkinsons-drug/
Short URL: http://invstplc.com/1nslelG